209 related articles for article (PubMed ID: 34710720)
21. Factors mediating cancer risk in systemic lupus erythematosus.
Hardenbergh D; Molina E; Naik R; Geetha D; Chaturvedi S; Timlin H
Lupus; 2022 Oct; 31(11):1285-1295. PubMed ID: 36059254
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia.
Liu H; Ding Q; Yang K; Zhang T; Li G; Wu G
Rheumatology (Oxford); 2011 Feb; 50(2):343-8. PubMed ID: 20929972
[TBL] [Abstract][Full Text] [Related]
23. Association between systemic lupus erythematosus and risk of cervical atypia: A meta-analysis.
Chen Y; Wu X; Liu L
Lupus; 2021 Nov; 30(13):2075-2088. PubMed ID: 34715754
[TBL] [Abstract][Full Text] [Related]
24. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.
Yurkovich M; Vostretsova K; Chen W; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):608-16. PubMed ID: 24106157
[TBL] [Abstract][Full Text] [Related]
25. Lupus and cancer.
Gayed M; Bernatsky S; Ramsey-Goldman R; Clarke A; Gordon C
Lupus; 2009 May; 18(6):479-85. PubMed ID: 19395448
[TBL] [Abstract][Full Text] [Related]
26. Malignancies in systemic lupus erythematosus: a 2015 update.
Goobie GC; Bernatsky S; Ramsey-Goldman R; Clarke AE
Curr Opin Rheumatol; 2015 Sep; 27(5):454-60. PubMed ID: 26125105
[TBL] [Abstract][Full Text] [Related]
27. Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies.
Zhang M; Wang Y; Wang Y; Bai Y; Gu D
Front Oncol; 2022; 12():860794. PubMed ID: 35600353
[TBL] [Abstract][Full Text] [Related]
28. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.
Kariniemi S; Rantalaiho V; Virta LJ; Kautiainen H; Puolakka K; Elfving P
Lupus; 2022 Dec; 31(14):1750-1758. PubMed ID: 36200539
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus and malignancies.
Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
[TBL] [Abstract][Full Text] [Related]
31. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
Wang B; Shao X; Wang D; Xu D; Zhang JA
Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
[TBL] [Abstract][Full Text] [Related]
32. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.
Fatoye F; Gebrye T; Mbada C
Rheumatol Int; 2022 Dec; 42(12):2097-2107. PubMed ID: 36006459
[TBL] [Abstract][Full Text] [Related]
33. Asymptomatic coronary artery disease assessed by coronary computed tomography in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Mendoza-Pinto C; Munguía-Realpzo P; García-Carrasco M; Godinez-Bolaños K; Rojas-Villarraga A; Morales-Etchegaray I; Ayón-Aguilar J; Méndez-Martínez S; Cervera R
Eur J Intern Med; 2022 Jun; 100():102-109. PubMed ID: 35410814
[TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
35. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden.
Nived O; Bengtsson A; Jönsen A; Sturfelt G; Olsson H
Lupus; 2001; 10(7):500-4. PubMed ID: 11480849
[TBL] [Abstract][Full Text] [Related]
36. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
[TBL] [Abstract][Full Text] [Related]
37. Managing cancer risk in patients with systemic lupus erythematous.
Ladouceur A; Bernatsky S; Ramsey-Goldman R; Clarke AE
Expert Rev Clin Immunol; 2018 Oct; 14(10):793-802. PubMed ID: 30183456
[TBL] [Abstract][Full Text] [Related]
38. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
39. Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta-analysis.
Wongtrakul W; Charoenngam N; Ponvilawan B; Ungprasert P
Int J Rheum Dis; 2020 Nov; 23(11):1460-1467. PubMed ID: 32749784
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
